Back to search

Article

Cutting Through the Artifacts: Dissecting gRNA Impurities with FUSS-seq

2025-09-17

Abstract excerpt

CRISPR-based therapeutics rely on guide RNAs (gRNAs) and the Cas9 endonuclease for precise gene editing. Ensuring gRNA purity and base-level sequence integrity is essential for clinical translation. While industry-standard practice relies on liquid chromatography-high-resolution mass spectrometry to assess oligonucleotide identity and purity, more recent FDA guidance recommends complementary base-by-base sequence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b467c0ac-bc63-5d57-9a6c-d49af2e00618
DOI
10.1101/2025.09.13.676056
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cutting Through the Artifacts: Dissecting gRNA Impurities with FUSS-seqDOI 10.1101/2025.09.13.676056
Select a neighboring publication to make it the new centre.